Cetrorelix (Cetrotide)
Overview
A synthetic decapeptide GnRH antagonist that competitively blocks pituitary GnRH receptors, producing immediate and dose-dependent suppression of LH and FSH without the initial flare effect seen with GnRH agonists.
Mechanism of Action
Cetrorelix prevents premature LH surges during controlled ovarian stimulation in IVF, allowing precise timing of oocyte maturation and retrieval..
Research Summary & Key Findings
FDA-approved for prevention of premature LH surges in women undergoing controlled ovarian stimulation for IVF. GnRH antagonist protocols (including cetrorelix) associated with significantly lower risk of ovarian hyperstimulation syndrome (OHSS) compared to agonist protocols. Flexible dosing allows initiation when lead follicle reaches 14 mm, reducing treatment burden.
Clinical Status
Cetrorelix (Cetrotide) has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.
Administration Routes
Related Peptides in Reproductive
Leuprolide (Lupron)
FDA ApprovedA synthetic nonapeptide GnRH agonist approximately 15-fold more potent than native GnRH. After an initial stimulatory ph...
View detailsGoserelin (Zoladex)
FDA ApprovedA synthetic decapeptide GnRH agonist administered as a biodegradable subcutaneous implant that provides sustained drug r...
View detailsGanirelix
FDA ApprovedA synthetic decapeptide GnRH antagonist that competitively and reversibly blocks GnRH receptors on pituitary gonadotroph...
View detailsCarbetocin
In Clinical TrialsA long-acting synthetic analog of oxytocin with a modified disulfide bridge that confers resistance to enzymatic degrada...
View detailsFind a Provider
Find a verified provider who offers Cetrorelix (Cetrotide) therapy in your area.
Browse Provider MapFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Cetrorelix (Cetrotide).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.